Dr Reddy's Laboratories inks pact with FUJIFILM, Global Response Aid

01 Jul 2020 Evaluate
Dr Reddy's Laboratories has partnered with FUJIFILM Corporation through FUJIFILM Toyama Chemical (FUJIFILM) and Global Response Aid (GRA) for the development, manufacture and sales of Avigan Tablets (generic name: favipiravir), a potential treatment of COVID-19. 
 
Under the tripartite agreement signed on June 30, 2020, FUJIFILM grants Dr. Reddy’s the exclusive rights of manufacturing and also grants both Dr. Reddy’s and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia. The company would have exclusive rights for development, selling and distribution of Avigan in India. Further, FUJIFILM would receive an upfront license fee and royalties on sales from Dr. Reddy’s and GRA. The FUJIFILM Group is currently conducting a clinical study on Avigan targeting COVID-19 patients in Japan and the US, and is working to increase the drug’s production by partnering with domestic and overseas companies. Dr. Reddy’s and GRA shall introduce the product in the market post all applicable approvals in the respective countries.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5904.90 -54.20 (-0.91%)
19-Apr-2024 13:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 5904.90
Cipla 1349.00
Zydus Lifesciences 917.10
Lupin 1544.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.